Recombinant PDCD1 (Cemiplimab Biosimilar) antibody
The Mammalian Cells Monoclonal anti-PDCD1 (Cemiplimab Biosimilar) antibody is suitable to detect PDCD1 (Cemiplimab Biosimilar) in samples from Human. It has been validated for ELISA.
Catalog No. ABIN7488185
$336.06
Plus shipping costs $50.00
Shipping to:
United States
Delivery in 7 to 8 Business Days
Quick Overview for Recombinant PDCD1 (Cemiplimab Biosimilar) antibody (ABIN7488185)
Target
PDCD1 (Cemiplimab Biosimilar)
Antibody Type
Recombinant Antibody
Reactivity
Human
Host
Mammalian Cells
Clonality
Monoclonal
Conjugate
This PDCD1 (Cemiplimab Biosimilar) antibody is un-conjugated
Application
ELISA
Grade
Research Grade
-
-
Expression System
- Mammalian cells
-
Purpose
- Cemiplimab Biosimilar - Anti-PDCD1, PD1, CD279 mAb
-
Characteristics
- Antibody Type: IgG4-kappa
-
Purification
- Recombinant antibody expressed in mammalien cells and purified.
-
Isotype
- IgG4 kappa
-
-
-
-
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS pH 7.5
-
Storage
- -80 °C
-
Storage Comment
- store at -80°C
-
-
- PDCD1 (Cemiplimab Biosimilar)
-
Target Type
- Biosimilar
-
Background
-
REGN-2810,SAR-439684,cemiplimab-rwlc
Cemiplimab (anti-PD-1) is an intravenous human monoclonal antibody directed against programmed cell death-1 receptor (PD-1) and blocks its interaction with programmed death ligands 1 (PD-L1) and 2 (PD-L2). Cemiplimab blocks T-cell inactivation and enhances the immune system's anti-tumor response. -
CAS-No
- 1801342-60-8
Target
-
You are here:
